UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis

Nature
2007.0

Abstract

Microglia, brain immune cells, engage in the clearance of dead cells or dangerous debris, which is crucial to the maintenance of brain functions. When a neighbouring cell is injured, microglia move rapidly towards it or extend a process to engulf the injured cell. Because cells release or leak ATP when they are stimulated or injured, extracellular nucleotides are thought to be involved in these events. In fact, ATP triggers a dynamic change in the motility of microglia in vitro and in vivo, a previously unrecognized mechanism underlying microglial chemotaxis; in contrast, microglial phagocytosis has received only limited attention. Here we show that microglia express the metabotropic P2Y6 receptor whose activation by endogenous agonist UDP triggers microglial phagocytosis. UDP facilitated the uptake of microspheres in a P2Y6-receptor-dependent manner, which was mimicked by the leakage of endogenous UDP when hippocampal neurons were damaged by kainic acid in vivo and in vitro. In addition, systemic administration of kainic acid in rats resulted in neuronal cell death in the hippocampal CA1 and CA3 regions, where increases in messenger RNA encoding P2Y6 receptors that colocalized with activated microglia were observed. Thus, the P2Y6 receptor is upregulated when neurons are damaged, and could function as a sensor for phagocytosis by sensing diffusible UDP signals, which is a previously unknown pathophysiological function of P2 receptors in microglia.

Knowledge Graph

Similar Paper

UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Nature 2007.0
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety
Bioorganic & Medicinal Chemistry 2012.0
Strategies for targeting the P2Y12 receptor in the central nervous system
Bioorganic & Medicinal Chemistry Letters 2022.0
Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y<sub>6</sub> Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications
Journal of Medicinal Chemistry 2010.0
Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub>Receptors
Journal of Medicinal Chemistry 2006.0
Purine and Pyrimidine (P2) Receptors as Drug Targets
Journal of Medicinal Chemistry 2002.0
5-OMe-UDP is a Potent and Selective P2Y<sub>6</sub>-Receptor Agonist
Journal of Medicinal Chemistry 2010.0
Human P2Y<sub>14</sub>Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl Groups
Journal of Medicinal Chemistry 2010.0
Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
Journal of Medicinal Chemistry 2005.0
Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2009.0